Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

CTSOCTSO
Showing 8 of 20 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in CYTOSORBENTS CORP

STIFEL FINANCIAL CORP holds 48,000 shares of CTSO (CYTOSORBENTS CORP), worth $17,952 as of 2026-Q2.

Current Value

$17,952

Current Shares

48,000

Total Value Change

-$49,548

Total Shares Change

+3,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
48,000
0.0%
$17,9520.0%$0.37
0
2026-Q1
Unchanged
48,000
0.0%
$27,1830.0%$0.80
0
2025-Q4
Unchanged
48,000
0.0%
$30,6820.0%$0.64
0
2025-Q3
Unchanged
48,000
0.0%
$44,8370.0%$0.93
0
2025-Q2
Unchanged
48,000
0.0%
$61,4400.0%$1.23
0
2025-Q1
Unchanged
48,000
0.0%
$48,0000.0%$1.00
0
2024-Q4
Increased
48,000
+6.7%
$43,6800.0%$0.90
15
2024-Q3
Unchanged
45,000
0.0%
$67,5000.0%$1.50
0

Other major holders of CTSO: BNP PARIBAS FINANCIAL MARKETS, Neuberger Berman Group LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used